This conceptual approach might be further indicative of additional implementation of the cytoprotection concept into eye pharmacotherapy and the whole occlusion/occlusion-like syndrome [18,19,20,21,22,23,24,25,26,27,28,29,30]
The short version: the Reddit consensus on Lemme is largely positive
A subset may develop other functional disorders like irritable bowel syndrome and migraine headaches
Expecting instant results
An elderly person who is treated with a GLP-1 agonist may then end up with significantly decreased food intake, which predisposes them to deficiency of important vitamins and minerals. Bottom line: Its important to discuss the benefits versus risks of GLP-1s with a healthcare provider before starting any new medication